Jump to Main Contents

Home > Organization > Division of Supportive Care Research(Tsukiji) > Research Summary

Research Summary

  • Support of projects regarding innovation of novel compounds in supportive and palliative care fields
  • First-in-human, second and third clinical trials to develop a novel analgesic for oral mucositis in cancer patients
  • Development of novel compounds for the inhibition of platelet-activating factor (PAF) signaling loop, the pathway causing progression of severe chronic pain
  • Development of novel and specific agonists for μ/δ opioid hetero-dimerized receptors
  • Development of compounds for the improvement of cancer cachexic symptoms: clinical application of ghrelin and des-acyl ghrelin for the inhibition of cardiac intoxication from chemotherapy and/or cancer cachexia
  • Research of Japanese kampo medicines to improve (QOL) in cancer patients